doi: 10.1007/BF00504757.
Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity
- PMID: 43476
- DOI: 10.1007/BF00504757
Item in Clipboard
Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity
Naunyn Schmiedebergs Arch Pharmacol.
1979 Nov.
No abstract available
Similar articles
-
An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.Neuropharmacology. 1982 Jun;21(6):539-43. doi: 10.1016/0028-3908(82)90044-2. Neuropharmacology. 1982. PMID: 7110537
-
Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.Naunyn Schmiedebergs Arch Pharmacol. 1976 Oct;295(1):15-20. doi: 10.1007/BF00509766. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 12482
-
Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.J Pharmacol Exp Ther. 1978 Dec;207(3):859-69. J Pharmacol Exp Ther. 1978. PMID: 731436
-
CNS dopamine autoreceptors: distribution, pharmacology, and function.Ann N Y Acad Sci. 1984;430:27-53. doi: 10.1111/j.1749-6632.1984.tb14497.x. Ann N Y Acad Sci. 1984. PMID: 6378032 Review. No abstract available.
-
Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endovenous dopamine after cessation of impulse flow.Biochem Pharmacol. 1976 Mar 15;25(6):649-54. doi: 10.1016/0006-2952(76)90239-2. Biochem Pharmacol. 1976. PMID: 6034 Review. No abstract available.
Cited by
-
Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.Am J Drug Alcohol Abuse. 2017 Nov;43(6):686-693. doi: 10.1080/00952990.2017.1339055. Epub 2017 Jun 29. Am J Drug Alcohol Abuse. 2017. PMID: 28662343 Free PMC article.
-
Evidence for down-regulation of GABA receptors following long-term gamma-butyrolactone.Naunyn Schmiedebergs Arch Pharmacol. 1984 Nov;328(1):62-8. doi: 10.1007/BF00496108. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6096730
-
Decreased 3H-L-quinuclidinyl benzilate binding and muscarine receptor subsensitivity after chronic gamma-butyrolactone treatment.Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(1):14-8. doi: 10.1007/BF00503306. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 7329448